Navigation Links
Patient Self-Monitoring: Devices, Markets, Players and Prospects

NEW YORK, Aug. 1, 2011 /PRNewswire/ -- announces that a new market research report is available in its catalogue:

Patient Self-Monitoring: Devices, Markets, Players and Prospects .html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

The ability of patients to monitor their own serum levels is deemed to be a critical tool in reducing the pathological effects of poorly controlled disease factors. For conditions other than diabetes, the vast majority of monitoring has until recently been performed in physician offices or similar healthcare settings. The convergence of new measurement technologies, patient demographics and managed care cost initiatives is driving patient monitoring for a number of conditions from caregiver facilities and into homes. In the process, patient self-monitoring for cholesterol, INR and hypertension have the potential to transition from a cottage industry into a significant market. The key enabler of this significant shift will be technological advances that will provide accurate readings in a format that consumers can understand, clearly indicating when a follow-up visit to a caregiver is needed. Systems that allow patients to share readings with physicians electronically have already been introduced. Ultimately, the success of this self-test market will rely on monitors that can provide accurate values for the various analytes that are associated with health risk, presenting them to the patient in the proper context..


• Analyzes and evaluates self-test monitoring technologies and products, and assesses the market potential, commercialization risks and opportunities

• Examines next-generatione monitor technologies, design issues and evolving market factors

• Provides forecasts and market data for self-monitoring products to 2015

• Assesses the impact and influence of self-monitoring enhancements on the healthcare management market

• Profiles self-monitoring market participants, their technology, product development activity, and business strategies

Executive Summary

Disease Management Market Dynamics

Patient Monitoring Overview

Key Factors in Patient Compliance

Market Drivers

Shifting Patient Demographics

Industry Alignment and Competitive Landscape

Self-Monitoring Technology Strategies

Needle-Stick Tests

Dry Chemistry Test Strips



Self-Collected / Mail-in Tests

Combination Meters

Continuous Monitors

Future Developments

Noninvasive Monitors





Signal Processing Advances

Monitor Product Design & Patient Issues


Measurement Frequency

Patient/User Interface


Data Collection/Data Display

Continuous vs Discrete Monitoring

Measurement Electronics




Sensor Technology

Self-Monitoring Therapeutic Segments

Atherosclerosis/Heart Disease (Cholesterol)

Total Cholesterol


Cholesterol Panel/Lipid Profile

Diabetes (Glucose)

OTC Meters

Alternate Site Testing

Continuous Monitoring

Heart Valve Replacement/Thrombosis

Oral Anticoagulation Therapy

Prothrombin Time

Hypertension (Blood Pressure)

Oscillometric Measurements

Demographic Trends

Self-Monitoring Product Segment Analysis

Cholesterol Monitors

FDA Approved Products

Products in Development

Coagulation Monitoring

FDA Approved Products

Products in Development

Glucose Monitors

Traditional Meters


Alternate Site Testing

Continuous Monitors

FDA-Approved Monitors

Development-stage Monitors

Noninvasive Glucose Monitors

Combination Monitors

Product Design Factors

FDA Approved Products


Existing Products

Emerging Technologies

Potential/Emerging Self-Monitoring Segments

Market Factors

Clinical Trial Issues

Regulations and Guidance

Managed care/Reimbursement

Patient Compliance

Marketing & Distribution

Sourcing/Private Labeling

Patient Self-Monitoring - Company Profile

To order this report:

In Vitro Diagnostic Industry: Patient Self-Monitoring: Devices, Markets, Players and Prospects    

In Vitro Diagnostic Business News

More  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
3. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
7. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
8. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
9. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
10. Many Heart Attack Patients Dont Get Best Emergency Treatment
11. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
Post Your Comments:
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on the ... announced that patient enrollment in its ongoing randomized ... has exceeded 50% of its 24-patient target. Capricor ... the third quarter of 2016, and to report ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van ... Wellness at Work award to iHire in recognition of their exemplary accomplishments in worksite ... 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association ... it will receive two significant new grants to support its work to advance ... 25th anniversary by recognizing patients, medical professionals and scientists for their work in ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited ... To Recovery® program to drive cancer patients to and from their cancer treatments. ... highest quality of life and ongoing independence. Getting to and from medical treatments ...
Breaking Medicine News(10 mins):